睑板腺功能障碍中炎症的临床相关免疫细胞指标
MGD患者上皮免疫细胞(EIC)和腺内免疫细胞(IGIC)显著升高,且与症状评分(OSDI)和泪膜破裂时间(TBUT)相关,检测炎症的ROC曲线下面积(AUC)分别达0.97和0.89。
要点
- MGD患者睑结膜EIC和IGIC显著高于对照,且与OSDI评分正相关、与TBUT负相关。
- EIC和IGIC检测睑结膜炎症的AUC分别为0.97和0.89,具有高准确性。
- 免疫细胞指标观察者间和观察者内一致性高(ρc 0.86-0.94,ICCa和Cronbach's α 0.85-0.97)。
核心结论
- EIC和IGIC在症状明显但角膜染色轻微的MGD患者中升高,并与症状和临床体征相关。
- EIC和IGIC可能提供可靠且临床相关的炎症指标。
研究设计与样本
- 所有受试者接受眼表检查、症状评估(OSDI问卷)和睑结膜IVCM成像。
- 采用Bland-Altman分析、组内相关系数(ICC)、Lin一致性相关系数(ρc)、ROC分析和相关性分析。
主要发现
- MGD患者平均OSDI评分为48.3 ± 7.6(P = 0.0008,范围8.3-85.42),TBUT为6.8 ± 0.9秒(P = 0.002),角膜染色为0.31 ± 0.19(P = 0.20)。
- MGD患者EIC为477.8 ± 54.2 cells/mm2,对照为123.3 ± 17.2 cells/mm2(P < 0.0001)。
- MGD患者IGIC为41.9 ± 3.3%,对照为20.33 ± 7.3%(P < 0.01)。
- EIC与OSDI正相关(rs: 0.49,P = 0.03),EIC和IGIC均与TBUT负相关(rs: -0.47、-0.45,P < 0.05)。
- EIC和IGIC检测炎症的ROC AUC分别为0.97和0.89(P ≤ 0.001)。
关键数值与推荐
- 免疫细胞指标观察者间和观察者内一致性高:ρc为0.86-0.94,ICC和Cronbach's α为0.85-0.97(P < 0.0001)。
临床怎么用
- IVCM衍生的EIC和IGIC可作为MGD相关睑结膜炎症的可靠量化指标,辅助评估症状与体征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the reliability and clinical relevance of in vivo confocal microscopy (IVCM)-based immune-cellular metrics of palpebral conjunctival inflammation in meibomian gland dysfunction (MGD). METHODS: Sixteen MGD patients and 13 reference controls included in this cross-sectional, retrospective study, had an ocular surface exam, symptom assessment (Ocular Surface Disease Index questionnaire [OSDI]), and palpebral conjunctival IVCM imaging. Bland-Altman analyses, intraclass correlation coefficient (ICCa), Lin's concordance correlation coefficient (ρc), receiver operating characteristic (ROC) analyses, and correlations were performed. Clinical outcome measures were symptom severity (OSDI scores), tear break-up time (TBUT), and corneal fluorescein staining (CFS grade). RESULTS: Compared to controls, patients with MGD had variable symptom severity (average OSDI score: 48.3 ± 7.6, P = 0.0008, range: 8.3-85.42), shorter TBUT (6.8 ± 0.9 seconds, P = 0.002), comparable corneal staining (0.31 ± 0.19, P = 0.20), and greater conjunctival inflammation (epithelial immune cells [EIC]: 477.8 ± 54.2 vs. 123.3 ± 17.2 cells/mm2, P < 0.0001; intraglandular immune cells [IGIC]: 41.9 ± 3.3% vs. 20.33 ± 7.3%, P < 0.01). Immune-cellular metrics had high inter- and intraobserver agreement (ρc: 0.86-0.94; ICCa and Cronbach's α: 0.85-0.97, P < 0.0001). EIC correlated positively with OSDI (rs: 0.49, P = 0.03), while both EIC and IGIC correlated inversely with TBUT (rs: -0.47, -0.45, P < 0.05), and had high accuracy in detecting inflammation (ROC area under the curve [AUC]: 0.97 and 0.89, P ≤ 0.001). CONCLUSIONS: EIC and IGIC are increased in highly symptomatic patients with MGD that have minimal corneal staining, and correlate with symptoms and clinical signs. EIC and IGIC may provide reliable and clinically relevant metrics of inflammation.
引用
- Qazi Y, Kheirkhah A, Blackie C, et al. Clinically Relevant Immune-Cellular Metrics of Inflammation in Meibomian Gland Dysfunction. Invest Ophthalmol Vis Sci. 2018. PMID: 30592499. doi:10.1167/iovs.18-25571
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。